Issn Print: 1462-8902
Publication Date: 2017/11/01
Neuropsychiatric safety with liraglutide 3.0 mg for weight management: Results from randomized controlled phase 2 and 3a trials
Patrick M. O'Neil; Vanita R. Aroda; Arne Astrup; Robert Kushner; David C. W. Lau; Thomas A. Wadden; Jason Brett; Ana‐Paula Cancino; John P. H. Wilding
Author Information: Weight Management Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.